AI-ACCELERATED DRUG DISCOVERY
Available from Reaxense
This protein is integrated into the Receptor.AI ecosystem as a prospective target with high therapeutic potential. We performed a comprehensive characterization of Nucleotide triphosphate diphosphatase NUDT15 including:
1. LLM-powered literature research
Our custom-tailored LLM extracted and formalized all relevant information about the protein from a large set of structured and unstructured data sources and stored it in the form of a Knowledge Graph. This comprehensive analysis allowed us to gain insight into Nucleotide triphosphate diphosphatase NUDT15 therapeutic significance, existing small molecule ligands, relevant off-targets, and protein-protein interactions.
Fig. 1. Preliminary target research workflow
2. AI-Driven Conformational Ensemble Generation
Starting from the initial protein structure, we employed advanced AI algorithms to predict alternative functional states of Nucleotide triphosphate diphosphatase NUDT15, including large-scale conformational changes along "soft" collective coordinates. Through molecular simulations with AI-enhanced sampling and trajectory clustering, we explored the broad conformational space of the protein and identified its representative structures. Utilizing diffusion-based AI models and active learning AutoML, we generated a statistically robust ensemble of equilibrium protein conformations that capture the receptor's full dynamic behavior, providing a robust foundation for accurate structure-based drug design.
Fig. 2. AI-powered molecular dynamics simulations workflow
3. Binding pockets identification and characterization
We employed the AI-based pocket prediction module to discover orthosteric, allosteric, hidden, and cryptic binding pockets on the protein’s surface. Our technique integrates the LLM-driven literature search and structure-aware ensemble-based pocket detection algorithm that utilizes previously established protein dynamics. Tentative pockets are then subject to AI scoring and ranking with simultaneous detection of false positives. In the final step, the AI model assesses the druggability of each pocket enabling a comprehensive selection of the most promising pockets for further targeting.
Fig. 3. AI-based binding pocket detection workflow
4. AI-Powered Virtual Screening
Our ecosystem is equipped to perform AI-driven virtual screening on Nucleotide triphosphate diphosphatase NUDT15. With access to a vast chemical space and cutting-edge AI docking algorithms, we can rapidly and reliably predict the most promising, novel, diverse, potent, and safe small molecule ligands of Nucleotide triphosphate diphosphatase NUDT15. This approach allows us to achieve an excellent hit rate and to identify compounds ready for advanced lead discovery and optimization.
Fig. 4. The screening workflow of Receptor.AI
Receptor.AI, in partnership with Reaxense, developed a next-generation technology for on-demand focused library design to enable extensive target exploration.
The focused library for Nucleotide triphosphate diphosphatase NUDT15 includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Nucleotide triphosphate diphosphatase NUDT15
partner:
Reaxense
upacc:
Q9NV35
UPID:
NUD15_HUMAN
Alternative names:
MutT homolog 2; Nucleoside diphosphate-linked moiety X motif 15; Nucleoside diphosphate-linked to another moiety X hydrolase 15
Alternative UPACC:
Q9NV35; A2RUR6; Q32Q27; Q6P2C9
Background:
Nucleotide triphosphate diphosphatase NUDT15, also known as MutT homolog 2, plays a crucial role in cellular processes by hydrolyzing nucleoside triphosphates and their oxidized forms. It is involved in the hydrolysis of dGTP, dTTP, dCTP, and thiopurine derivatives, indicating its potential in DNA synthesis and cell cycle progression. NUDT15's ability to sanitize oxidatively damaged nucleosides and stabilize PCNA underscores its multifaceted role in maintaining genomic integrity.
Therapeutic significance:
Understanding the role of Nucleotide triphosphate diphosphatase NUDT15 could open doors to potential therapeutic strategies. Its involvement in the catabolism of thiopurine drugs and DNA synthesis presents a unique opportunity for targeting in drug discovery, especially in conditions where DNA repair and synthesis pathways are compromised.
